Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

Half Year Trading Update

30 Sep 2013 07:00

RNS Number : 1662P
Science in Sport PLC
30 September 2013
 



For immediate release

30 September 2013

 

SCIENCE IN SPORT PLC

("SiS" or the "Company")

 

Half Year Trading Update

Science in Sport plc (AIM: SIS), a leading sports nutrition company, is pleased to announce the following pre-close trading update ahead of its financial results for the half year ended 30 September 2013.

The Board is pleased to report another period of significant revenue growth with sales expected to be up 23 per cent, compared with the same period last year, at approximately £3.95 million.

Revenue growth in the half year has been driven by strong sales of isotonic gels, food bars and hydration tablets and reflects the Company's on-going investment in product innovation, sales and marketing.

The revenue growth highlights the strength of the SiS brand and the resilience of the sports nutrition category. The growth was evident in all channels including major grocers, high street outlets, independent retailers and e-commerce, as well as in international markets.

Pre-tax profits for the half year are expected to be in line with management expectations and the Board remains confident of the outlook for continued revenue growth in the full year.

Science in Sport intends to issue its half year results in early December 2013.

 

For further information:

Science in Sport PLC

+44 (0) 1753 861722

Stephen Moon, CEO

Cenkos Securities

+44 (0) 20 7397 8900

Bobbie Hilliam - NOMAD and Broker

Buchanan

+44 (0) 20 7466 5000

Mark Court / Sophie McNulty / Fiona Henson

sis@buchanan.uk.com

 

About Science in Sport plc

Science in Sport plc is a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts. SiS is a strong brand in the elite athlete community - in the 2012 London Olympics, 24 medal-winning athletes or teams used SiS products.

The SiS core product ranges include: SiS GO, comprising energy powders, isotonic gels, energy bars and hydration tablets; and SiS REGO, including protein-based recovery powders and bars. SiS products are sold in a range of retail channels, including specialist sport retailers, major grocers, high street retailers and e-commerce websites.

SiS is currently the official sports nutrition supplier to cycling teams Rapha Condor JLT, Belkin Pro Cycling, Madison Genesis, Pro Team Astana and Team Katusha. SiS is also currently the official supplier of sports drinks and sports nutrition to the GB Rowing Team. Mark Cavendish, the Manx Missile, is an elite sports consultant and Olympians Sir Chris Hoy, Helen Jenkins and Rebecca Romero are official brand ambassadors.

SiS was founded in 1992 and is headquartered in Windsor, Berkshire. Its manufacturing facility is in Nelson, Lancashire.

SiS shares are traded on the AIM market of the London Stock Exchange under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFVEAFIDFIV
Date   Source Headline
20th Feb 202311:14 amRNSForm 8.3 - Science in Sport PLC
20th Feb 20238:50 amRNSForm 8.5 (EPT/RI)
10th Feb 202312:30 pmRNSForm 8.3 - Science in Sport PLC
10th Feb 20239:59 amRNSForm 8.5 (EPT/RI)
1st Feb 202312:57 pmRNSNotification of major holdings
27th Jan 20231:09 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: SCIENCE IN SPORT GB00BBPV5329
27th Jan 202312:46 pmRNSForm 8.3 - Science in Sport PLC
25th Jan 20231:51 pmRNSForm 8.3 - Science in Sport PLC
24th Jan 20231:25 pmRNSForm 8.3 - Science in Sport PLC - REPLACEMENT
23rd Jan 20238:41 amRNSAppointment of Non-Executive Director
20th Jan 20239:26 amRNSForm 8.5 (EPT/RI)
18th Jan 202310:54 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Science in Sport Plc.
17th Jan 20231:41 pmRNSForm 8.3 - Science in Sport PLC
17th Jan 202310:56 amRNSForm 8.5 (EPT/RI)
17th Jan 202310:37 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Science in Sport Plc.
16th Jan 202311:15 amRNSForm 8.3 - Science In Sports plc
16th Jan 20238:36 amRNSForm 8.5 (EPT/RI)
12th Jan 20238:39 amRNSForm 8.5 (EPT/RI)
9th Jan 202311:49 amRNSForm 8.3 - Science in Sport PLC
4th Jan 20239:35 amRNSForm 8.5 (EPT/RI)
28th Dec 20229:45 amRNSForm 8.5 (EPT/RI)
23rd Dec 20228:35 amRNSForm 8.5 (EPT/RI)
22nd Dec 20229:45 amRNSForm 8.3 - Science in Sport PLC
21st Dec 20228:35 amRNSForm 8.5 (EPT/RI)
20th Dec 202212:53 pmRNSForm 8.3 - Science in Sport PLC
20th Dec 20228:33 amRNSForm 8.5 (EPT/RI)
19th Dec 20229:06 amRNSForm 8.5 (EPT/RI)
16th Dec 20222:55 pmRNSForm 8.3 - Science in Sport PLC
16th Dec 20228:40 amRNSForm 8.5 (EPT/RI)
15th Dec 20222:42 pmRNSForm 8.3 - Science in Sport PLC
15th Dec 202210:32 amRNSForm 8.3 - Science in Sport PLC
15th Dec 202210:15 amRNSForm 8.3 - Science in Sport Plc
15th Dec 20228:54 amRNSForm 8.5 (EPT/RI)
14th Dec 20228:52 amRNSForm 8.5 (EPT/RI)
13th Dec 20229:07 amRNSForm 8.5 (EPT/RI)
12th Dec 202211:42 amRNSForm 8.3 - Science in Sport PLC
12th Dec 20229:59 amRNSForm 8.3 - Science in Sport PLC
12th Dec 20228:59 amRNSForm 8.5 (EPT/RI)
9th Dec 20221:13 pmRNSForm 8.3 - Science in Sport PLC
9th Dec 202211:26 amRNSForm 8.3 - Science in Sport PLC
9th Dec 202211:09 amRNSForm 8.3 -Science in Sport plc
8th Dec 20221:02 pmRNSForm 8.3 - Science in Sport PLC
8th Dec 202210:38 amRNSForm 8.3 - Science in Sport PLC
7th Dec 20221:04 pmRNSForm 8.3 - Science in Sport plc
6th Dec 20221:29 pmRNSForm 8.3 - Science in Sport PLC
6th Dec 20221:14 pmRNSForm 8.3 - Science In Sport PLC
6th Dec 20229:21 amRNSForm 8.5 (EPT/RI)
5th Dec 20221:49 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Science in Sport Plc.
2nd Dec 20222:00 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Science in Sport Plc.
2nd Dec 202211:49 amRNSForm 8.3 - Science in Sport PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.